SMA Biomarkers
Biomarkers are medical indicators that can be measured to inform us of the progress of a disease.
For example, the amount of a particular protein found in a blood or urine sample may have a strong correlation with the phase of a disease; measuring the amount of this protein will then help us to better assess the state of the disease.
Reliable biomarkers can therefore also help to determine whether a particular therapy is having the desired positive effect on a disease, as the levels of the biomarkers should be responsive to effective treatments.
Research is being conducted to find a dependable set of biomarkers for SMA, which will be an invaluable tool for helping to assess the effectiveness of potential therapies in SMA clinical trials.
Progress with SMA Biomarkers
2021
Biogen Presents New Data from its DEVOTE Study of Spinraza (nusinersen)
2019
Potential Biomarker for SMA Identified
2012
Biomarkers for SMA Clincial study published
The sMA foundation and myriad rbm launch sma biomarker panel
